Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres

PURPOSE: To evaluate the response rate and safety of superselective drug-eluting beats transarterial chemoembolization (DEB-TACE) with doxorubicin-loaded 40-µm microspheres in patients with hepatocellular carcinoma (HCC). METHODS: One hundred and forty-one treatments with doxorubicin-loaded 40-µm mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Katharina Carolin, Aschenbach, René, Diamantis, Ioannis, Eckardt, Niklas, Teichgräber, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810642/
https://www.ncbi.nlm.nih.gov/pubmed/32880029
http://dx.doi.org/10.1007/s00432-020-03370-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810642/
https://www.ncbi.nlm.nih.gov/pubmed/32880029
http://dx.doi.org/10.1007/s00432-020-03370-z

Ejemplares similares